A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.

NCT07347275 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute-on-Chronic Liver Failure (ACLF)
Liver Cirrhosis

Interventions

OTHER: Standard of Care (Investigator Choice)
DEVICE: DIALIVE 2.0 liver dialysis Device plus available Standard of Care

Sponsor

Yaqrit Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]